FDA approves Gablofen for spasticity

FDA approved an NDA from CNS Therapeutics Inc. (St. Paul, Minn.) for Gablofen baclofen injection to manage severe spasticity. The application was submitted under section 505(b)(2) of the Food, Drug an...